Clinical Trial Update: A Study to Evaluate Emapalumab in Japanese Healthy Volunteers. [Phase 1]

View source ↗

Summary

Phase 1 study evaluating emapalumab in Japanese healthy volunteers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rare Disease

Drugs mentioned

• Emapalumab (emapalumab)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Rare Diseases | Phase 1 | Status: COMPLETED | Results posted: 2023-11-24